Another study showed that cisplatin-based chemoradiation (2 × 12Gy) combined with anti-PD-1 antibody significantly improved RT-induced abscopal effects in MC38 colon cancer and B16 melanoma models [72]. This evidence concerns the gene PDCD1 and colonic neoplasm.